Life science venture capital fund actively investing in early-stage (Series A, pre-A, B) disruptive life science tools and therapeutics companies.

Corporate VC, Ophthalmology focused

Syneos Health® is the only fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into ou ...

Vincere is advancing disease-modifying small molecules for Parkinson’s by boosting mitophagy. Currently in the IND-enabling phase, our highly potent and selective USP30 inhibitors are nearing the idea ...

At WoodGreen Ventures, our mission is to partner with innovative life science firms to improve people's lives and advance novel products.

Aegle Therapeutics is an early clinical-stage biopharmaceutical company developing novel therapies to treat epidermolysis bullosa and other rare and severe dermatological disorders.

Ascenta Capital is a biotech-focused late-stage venture fund, co-founded in 2023 by Dr. Evan Rachlin and Dr. Lorence Kim. The fund is focused on concentrated investments in companies developing portfo ...

DeepWork is an early-stage VC investing across Life Sciences and Tech. In addition to our venture funds, we also manage all of the State of FL's venture funds.

We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approac ...

Mid Atlantic Bio Angels group (BioAngels), is an angel investor group focused exclusively on new and emerging life science companies in the therapeutics, devices and diagnostics space.